Lipases and Phospholipases in Drug Development: From Biochemistry to Molecular Pharmacology

Author:   G Müller ,  Stefan Petry
Publisher:   Wiley-VCH Verlag GmbH
ISBN:  

9783527306770


Pages:   354
Publication Date:   02 March 2004
Format:   Hardback
Availability:   Awaiting stock   Availability explained


Our Price $594.00 Quantity:  
Add to Cart

Share |

Lipases and Phospholipases in Drug Development: From Biochemistry to Molecular Pharmacology


Add your own review!

Overview

Full Product Details

Author:   G Müller ,  Stefan Petry
Publisher:   Wiley-VCH Verlag GmbH
Imprint:   Wiley-VCH Verlag GmbH
Dimensions:   Width: 18.60cm , Height: 2.30cm , Length: 24.70cm
Weight:   0.836kg
ISBN:  

9783527306770


ISBN 10:   3527306773
Pages:   354
Publication Date:   02 March 2004
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Awaiting stock   Availability explained

Table of Contents

Reviews

"""Historical and state-of-the-art information is provided. The international authorship enhances the relevance of the book...the text is well-written and understandable."" (E-STREAMS, January 2005)"


Historical and state-of-the-art information is provided. The international authorship enhances the relevance of the book...the text is well-written and understandable. (E-STREAMS, January 2005)


Author Information

Gunter Muller is senior scientist for Biochemistry at Aventis Pharma Germany, Frankfurt am Main, and honorary lecturer for genetics at the University of Munich. He was born in Peissenberg (Germany) and studied anthropology, zoology, genetics and biochemistry at the Ludwig-Maximilians-University in Munich, finishing his PhD thesis under the supervision of R. Zimmermann in 1987. After post-doctoral fellowships at the universities of Ulm and Heidelberg, he joined the pharmaceutical industry in 1990 and received his habilitation at the University of Munich in 1996. He is interested in molecular mechanisms in both lower eukaryotes and mammalian cells, and their use as drug targets for metabolic disorder. Stefan Petry is senior scientist in Medicinal Chemistry at Aventis Germany, Frankfurt am Main. He was born in Kaiserslautern (Germany) and studied Chemistry and Biochemistry at the Albert-Ludwigs-University in Freiburg, including his PhD thesis under the supervision of Jochen Lehmann on photo-affinity labeling of carbohydrate binding proteins. He joined the pharmaceutical industry in 1994. At Aventis he is responsible for projects in the field of diabetes. In particular, he is interested in the development of small molecules which interact with signal transduction processes or influence lipid metabolism.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List